SciSparc (SPRC) Other Operating Expenses (2016 - 2019)

SciSparc (SPRC) posted Other Operating Expenses of $1.0 million for Q1 2019, up 3938.46% sequentially from $26000.0 in Q2 2016.

SciSparc (SPRC) Other Operating Expenses (2016 - 2019) Analysis & Trends

SciSparc has reported Other Operating Expenses for 2 years, with the latest figure at $1.0 million in Q1 2019.

Quarterly Other Operating Expenses changed N/A year-over-year to $1.0 million in Q1 2019, while the trailing twelve-month figure through Jun 2020 was $1.0 million (changed 0.0% YoY) and the FY2020 annual result came in at -$742000.0, changed N/A from the prior year.
Other Operating Expenses advanced to $1.0 million in Q1 2019 per SPRC's latest filing, from $26000.0 in the prior quarter.
Over five years, Other Operating Expenses peaked at $1.0 million in Q1 2019 and troughed at $26000.0 in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	SciSparc	831,418.60	831,418.60	-

Download Data

Date	Value
Mar 31, 2019	1.05 Mn
Jun 30, 2016	26,000.00